| DC Field | Value | Language |
|---|
| dc.contributor.author | Elnora Djurayeva1., Masuda Kasimova1., Sevara Mukhamadiyeva1., Nigora Akhmedova1., Nargiza Abduazizova1 | - |
| dc.date.accessioned | 2026-10-20T06:32:13Z | - |
| dc.date.available | 2026-10-20T06:32:13Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.uri | http://repo.tma.uz/xmlui/handle/1/5543 | - |
| dc.description.abstract | The article presents modern data on the influence of the most common
polymorphisms SLC2A9 and ABCG2 of genes encoding proteins that are involved in
the renal urate transport system and, thus, associated with the level of uric acid or
gout. Characterization of polymorphisms SLC2A9 and ABCG2 of genes: V253I,
Q126X, Q141K was carried out. It was determined that the GCA and GTC
haplotypes of the Q126X and Q141K polymorphisms can be predictors of gout. The
interrelation of SLC2A9 and ABCG2 gene polymorphisms with the presence of
hyperuricemia depending on gender, components of metabolic syndrome, and
response to allopurinol was analyzed. Most genes associated with MK or gout in a
genome-wide association study encode proteins that are involved in the renal urate
transport system, for example, SLC2A9 (solute carrier family 2, member 9) and
ABCG2 (ATP-binding cassette, family G) are well-known genes for urate
transporters responsible for their reabsorption and excretion. Thus, the determination
of polymorphism - SLC2A9 and ABCG2 genes can help in diagnosing the risk of
developing gout and optimizing the schemes of uricosuric therapy in patients with
refractory gout | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | CHINA (Chin J Ind Hyg Occup Dis) No.7 | en_US |
| dc.subject | hyperuricaemia, gout, ABCG2, SLC2A9, gene polymorphism | en_US |
| dc.title | Clinical predictors of gene polymorphism in the occurrence of hyperuricemia and gout | en_US |
| dc.type | Article | en_US |
| Appears in Collections: |
|
